1. Home
  2. BIAF vs NWTG Comparison

BIAF vs NWTG Comparison

Compare BIAF & NWTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • NWTG
  • Stock Information
  • Founded
  • BIAF 2014
  • NWTG 2018
  • Country
  • BIAF United States
  • NWTG United States
  • Employees
  • BIAF N/A
  • NWTG N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • NWTG Recreational Games/Products/Toys
  • Sector
  • BIAF Health Care
  • NWTG Consumer Discretionary
  • Exchange
  • BIAF Nasdaq
  • NWTG Nasdaq
  • Market Cap
  • BIAF 7.6M
  • NWTG 8.5M
  • IPO Year
  • BIAF 2022
  • NWTG N/A
  • Fundamental
  • Price
  • BIAF $3.24
  • NWTG N/A
  • Analyst Decision
  • BIAF Hold
  • NWTG
  • Analyst Count
  • BIAF 1
  • NWTG 0
  • Target Price
  • BIAF N/A
  • NWTG N/A
  • AVG Volume (30 Days)
  • BIAF 7.6M
  • NWTG 137.2K
  • Earning Date
  • BIAF 11-13-2025
  • NWTG 11-13-2025
  • Dividend Yield
  • BIAF N/A
  • NWTG N/A
  • EPS Growth
  • BIAF N/A
  • NWTG N/A
  • EPS
  • BIAF N/A
  • NWTG N/A
  • Revenue
  • BIAF $7,681,059.00
  • NWTG $5,560,000.00
  • Revenue This Year
  • BIAF N/A
  • NWTG $117.56
  • Revenue Next Year
  • BIAF $20.04
  • NWTG $51.43
  • P/E Ratio
  • BIAF N/A
  • NWTG N/A
  • Revenue Growth
  • BIAF 4.99
  • NWTG 304.36
  • 52 Week Low
  • BIAF $2.34
  • NWTG $1.35
  • 52 Week High
  • BIAF $67.12
  • NWTG $119.10
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 53.34
  • NWTG 44.48
  • Support Level
  • BIAF $2.36
  • NWTG $1.63
  • Resistance Level
  • BIAF $7.29
  • NWTG $1.81
  • Average True Range (ATR)
  • BIAF 0.63
  • NWTG 0.12
  • MACD
  • BIAF -0.30
  • NWTG -0.01
  • Stochastic Oscillator
  • BIAF 23.73
  • NWTG 27.27

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About NWTG Newton Golf Company Inc. Common Stock

Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.

Share on Social Networks: